Boston, MA · Founded 2020 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop novel neuropsychiatric medicines in areas of patient need. Seaport Therapeutics is based in Boston, MA and was founded in 2020. It is valued at about $740 million as of Oct 2026, set by institutional fund marks. It has raised $330 million across 1 recorded round; the latest was a $226 million later-stage round in Oct 2024.
PMV mark · valuation
$740.0M
Oct 2026
Priced at
its later-stage round
Oct 2024
Total raised
$329.9M
Last round
Later Stage VC
Oct 2024
Cap table — not yet on record
Seaport Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Seaport Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Seaport Therapeutics's 1 recorded funding rounds.
